glucagon has been researched along with Coronary Heart Disease in 53 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 46 (86.79) | 18.7374 |
1990's | 3 (5.66) | 18.2507 |
2000's | 3 (5.66) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (1.89) | 2.80 |
Authors | Studies |
---|---|
Alcala-Diaz, JF; Caballero-Villarraso, J; Gonzalez-Requero, A; Leon-Acuña, A; Lopez-Miranda, J; Luque, RM; Ordovas, JM; Pérez-Martinez, P; Pozuelo-Sanchez, I; Quesada, I; Roncero-Ramos, I; Vals-Delgado, C; Villasanta-Gonzalez, A; Yubero-Serrano, EM | 1 |
Ahrén, B; Gutniak, MK; Holst, JJ; Nyström, T; Sjöholm, A; Zhang, F; Zhang, Q | 1 |
Opie, LH | 1 |
Hartung, H; Kirchner, R | 1 |
Barth, JD; Birkenhäger, JC; Hugenholtz, PG; Jansen, H | 1 |
Amano, J; Okamura, T; Sunamori, M; Suzuki, A | 1 |
Gitel', EP; Gur'ianova, LN; Makolkin, VI; Pomerantsev, EV; Vakhliaev, VD | 1 |
Hill, NE; Mookherjee, S; Patel, DG; Potts, JL; Raheja, KL; Smulyan, H; Vardan, S; Warner, R | 1 |
Bloom, SR; Wood, SM | 1 |
Langer, B; McLoughlin, MJ; Wilson, DR | 1 |
Losert, U; Ramadan, I; Wolner, E | 1 |
Fletcher, JM; Knapper, JM; Morgan, LM | 1 |
Brynes, A; Frost, G; Leeds, A | 1 |
Gill, JM; Hardman, AE | 1 |
Bloom, SR; Brynes, AE; Edwards, CM; Frost, GS; Ghatei, MA | 1 |
Kirsh, MM; Lucchesi, B; Peterson, A | 1 |
Castaldi, C; D'Amore, F; Materia, E; Mauceri, M; Rivosecchi, L | 1 |
Eaton, RP; Lueker, R; Schade, DS | 1 |
Berk, RN; Higgins, CB; Karliner, JS; O'Rourke, R; Roeske, WR | 1 |
Nelius, D | 1 |
Berestov, AA; Golikov, AP | 1 |
Artese, D; Di Nicola, A; Santilli, S | 1 |
Broekhoven-Schokker, S; Hülsmann, WC; Schoonderwoerd, K; Stam, H | 1 |
Loveday, EJ; Rowland-Hill, CA; Thomas, ML | 1 |
de Waard, F; Garbaczewski, L; Hill, P; Koppeschaar, H; Thijssen, JH; Wynder, EL | 1 |
Filin, VI; Ianovskaia, SI; Krylov, AA | 1 |
Birkigt, HG; Ebner, E; Mäder, I; Riedel, E; Sedlarik, KM; Seelig, G | 1 |
Frick, MH; Härkönen, M; Huttunen, JK | 1 |
McCallister, BD | 1 |
Goodwin, JF | 1 |
Leighton, RF; Polumbo, RA; Weissler, AM | 1 |
Katz, J; Rabinowitz, B | 1 |
Faloona, GR; Hutcheson, DR; Leshin, SJ; Unger, RH; Willerson, JT | 1 |
Asai, Y | 1 |
Gabe, I; Jewitt, D; Maurer, B; Mills, C; Shillingford, J; Thomas, M | 1 |
Hosoda, S | 1 |
Brawley, RK; Furuse, A; Gott, VL | 1 |
Kjekshus, JK; Lekven, J; Mijös, OD | 1 |
De Thomatis, M | 1 |
Lombardo, AA; Shaver, JC; Shaver, VC | 1 |
Abboud, FM; Eckberg, DL; Kerber, RE; Marcus, ML | 1 |
Shaver, JC; Shaver, VC | 1 |
Brooks, DK; Butler, WT; De Bakey, ME; Diethrich, EB; Glick, G; Liddicoat, JE; Noon, GP; Rossen, RD | 1 |
Krotkiewski, A | 1 |
Armstrong, PW; Austen, WG; Daggett, WM; Gold, HK; Sanders, CA | 1 |
Kedrowa, S | 1 |
Frye, RL; Greenberg, BH; McCallister, BD | 1 |
Fortner, RB; Nishimura, A; Williams, JF | 1 |
Bing, RJ; Cowan, CM; Goldschlager, N; Leb, G; Robin, E | 1 |
Koch-Weser, J | 1 |
Bourassa, MG; Campeau, L; Eibar, J | 1 |
Braunwald, E; Covell, JW; Kjekshus, JK; Maroko, PR; Ross, J; Sobel, BE; Watanabe, T | 1 |
Connor, WE; Hoak, JC; Warner, ED | 1 |
6 review(s) available for glucagon and Coronary Heart Disease
Article | Year |
---|---|
[Diagnosis and therapy of acute pancreatitis (author's transl)].
Topics: Acute Disease; Anti-Bacterial Agents; Appendicitis; Aprotinin; Atropine; Calcitonin; Cholecystitis; Coronary Disease; Diagnosis, Differential; Drainage; Edema; Glucagon; Hemorrhage; Humans; Mesenteric Arteries; Pancreas; Pancreatitis; Peptic Ulcer Perforation; Radiography, Abdominal; Radiography, Thoracic; Thromboembolism | 1980 |
Nutrient-induced secretion and metabolic effects of glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1.
Topics: Adaptation, Physiological; Adipose Tissue; Animals; Coronary Disease; Diabetes Mellitus, Type 2; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptides; Humans; Obesity; Peptide Fragments | 1996 |
[Changes in the cardiovascular system in acute pancreatitis].
Topics: Acute Disease; Adrenal Glands; Blood Volume; Cardiac Output; Cardiovascular System; Coronary Disease; Electrocardiography; Energy Metabolism; Glucagon; Hemodynamics; Humans; Liver Circulation; Microcirculation; Middle Aged; Myocardial Depressant Factor; Myocardium; Necrosis; Pancreatitis; Shock; Vascular Resistance | 1986 |
[Heart failure caused by sclerotic coronary diseases and hypertension and its management].
Topics: Angina Pectoris; Arrhythmias, Cardiac; Chronic Disease; Coronary Disease; Digitalis Glycosides; Diuretics; Electrocardiography; Glucagon; Glucocorticoids; Heart Failure; Humans; Hypertension; Myocardial Infarction; Radiography | 1972 |
[Advances in cardiology. Therapy].
Topics: Angiography; Anti-Arrhythmia Agents; Coronary Angiography; Coronary Disease; Glucagon; Heart; Heart Diseases; Humans; Injections, Intravenous; Myocardial Infarction | 1971 |
[Effect of glucagon on the circulatory system].
Topics: Animals; Blood Circulation; Blood Pressure; Cats; Coronary Disease; Dogs; Gastrointestinal Motility; Glucagon; Heart; Heart Conduction System; Humans; Injections, Intravenous; Insulin; Insulin Secretion; Myocarditis; Pulmonary Heart Disease; Shock, Cardiogenic; Time Factors | 1971 |
4 trial(s) available for glucagon and Coronary Heart Disease
Article | Year |
---|---|
Postprandial Lipemia Modulates Pancreatic Alpha-Cell Function in the Prediction of Type 2 Diabetes Development: The CORDIOPREV Study.
Topics: Coronary Disease; Diabetes Mellitus, Type 2; Disease Progression; Female; Glucagon; Glucagon-Secreting Cells; Humans; Hyperlipidemias; Lipid Metabolism; Male; Middle Aged; Postprandial Period; Prospective Studies; Triglycerides | 2020 |
Effects of glucagon-like peptide-1 on endothelial function in type 2 diabetes patients with stable coronary artery disease.
Topics: Adult; Brachial Artery; Coronary Circulation; Coronary Disease; Coronary Vessels; Cross-Over Studies; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Endothelial Cells; Endothelium, Vascular; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Humans; Insulin; Male; Middle Aged; Nitroglycerin; Peptide Fragments; Pilot Projects; Protein Precursors; Receptors, Glucagon; Regional Blood Flow; Vasodilation | 2004 |
Men at increased risk of coronary heart disease are not different from age- and weight-matched healthy controls in their postprandial triglyceride, nonesterified fatty acid, or incretin responses to sucrose.
Topics: Blood Glucose; Case-Control Studies; Coronary Disease; Fatty Acids, Nonesterified; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptides; Humans; Male; Peptide Fragments; Postprandial Period; Risk Factors; Sucrose; Triglycerides | 2002 |
A comparison of the value of hyoscine butylbromide and glucagon on aorto iliac intravenous digital subtraction.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Angiography, Digital Subtraction; Arrhythmias, Cardiac; Butylscopolammonium Bromide; Coronary Disease; Electrocardiography; Female; Glucagon; Humans; Male; Middle Aged; Random Allocation; Scopolamine Derivatives | 1989 |
43 other study(ies) available for glucagon and Coronary Heart Disease
Article | Year |
---|---|
Drugs and the heart. V. Digitalis and sympathomimetic stimulants.
Topics: Arrhythmias, Cardiac; Cell Membrane; Coronary Disease; Digitalis Glycosides; Glucagon; Heart Failure; Humans; Kinetics; Myocardial Contraction; Myocardium; Potassium; Receptors, Drug; Stimulation, Chemical; Sympathomimetics | 1980 |
Post-heparin lipases, lipids and related hormones in men undergoing coronary arteriography to assess atherosclerosis.
Topics: Adult; Cholesterol; Cholesterol, HDL; Coronary Disease; Estradiol; Glucagon; Growth Hormone; Heparin; Hormones; Humans; Hydrocortisone; Insulin; Lipase; Lipids; Lipoprotein Lipase; Lipoproteins, HDL; Liver; Male; Middle Aged; Prolactin; Radiography; Testosterone; Thyroid Hormones | 1983 |
Metabolic effect of glucose, insulin and potassium cardioplegia.
Topics: Blood Glucose; Coronary Artery Bypass; Coronary Disease; Electrocardiography; Fatty Acids, Nonesterified; Glucagon; Glucose Solution, Hypertonic; Growth Hormone; Heart Arrest, Induced; Humans; Insulin; Male; Middle Aged; Myocardium; Potassium | 1983 |
[Insulin and glucagon content of coronary sinus and left ventricle blood in myocardial ischemia].
Topics: Adult; Blood Glucose; Coronary Disease; Coronary Vessels; Fatty Acids, Nonesterified; Glucagon; Heart Ventricles; Humans; Insulin; Lactates; Male; Middle Aged; Neurocirculatory Asthenia | 1983 |
Lack of relationship between plasma insulin and glucagon levels and angiographically-documented coronary atherosclerosis.
Topics: Blood Glucose; Cardiac Catheterization; Cholesterol; Coronary Angiography; Coronary Disease; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Glucagon; Humans; Insulin; Male; Middle Aged; Triglycerides | 1984 |
Glucagon and gastrin secretion by a pancreatic tumour and its metastases.
Topics: Aged; Coronary Disease; Gastrins; Glucagon; Humans; Liver Neoplasms; Male; Pancreatic Neoplasms; Pancreatic Polypeptide | 1982 |
Life-threatening reaction to glucagon in a patient with pheochromocytoma.
Topics: Adrenal Gland Neoplasms; Adult; Coronary Disease; Female; Glucagon; Humans; Pheochromocytoma; Tomography, X-Ray Computed | 1981 |
[Hemodynamic changes following acute myocardial ischemia and zinc-protamine-glucagon application in dogs (author's transl)].
Topics: Animals; Blood Pressure; Coronary Disease; Dogs; Drug Combinations; Glucagon; Hemodynamics; Protamines; Regional Blood Flow; Zinc | 1980 |
Effect of large bowel fermentation on insulin, glucose, free fatty acids, and glucagon-like peptide 1 (7-36) amide in patients with coronary heart disease.
Topics: Aged; Blood Glucose; Coronary Disease; Fatty Acids, Nonesterified; Fermentation; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptides; Glucose Tolerance Test; Humans; Insulin; Insulin Resistance; Intestinal Absorption; Intestine, Large; Lactulose; Male; Middle Aged; Peptide Fragments; Risk Factors | 1999 |
Postprandial lipemia: effects of exercise and restriction of energy intake compared.
Topics: Blood Glucose; Coronary Disease; Energy Intake; Exercise; Exercise Test; Fasting; Fatty Acids; Female; Food Deprivation; Glucagon; Humans; Insulin; Lipids; Middle Aged; Postmenopause; Postprandial Period; Triglycerides | 2000 |
The effect of glucagon in animals on chronic propranolol therapy.
Topics: Animals; Blood Pressure; Cardiac Output; Cardiopulmonary Bypass; Coronary Disease; Dogs; Glucagon; Heart Rate; Hemodynamics; Isoproterenol; Propranolol; Stimulation, Chemical | 1978 |
[Treatment of refractory cardiac insufficiency with infusion of glucagon, insulin, glucose and potassium].
Topics: Aged; Arrhythmias, Cardiac; Coronary Disease; Drug Combinations; Drug Evaluation; Female; Glucagon; Glucose; Heart Block; Heart Failure; Humans; Infusions, Parenteral; Insulin; Potassium | 1978 |
Clofibrate-induced changes in glucagon and insulin secretion in patients with angiographically documented coronary artery disease.
Topics: Adult; Arginine; Clofibrate; Coronary Disease; Female; Glucagon; Humans; Insulin; Insulin Secretion; Male; Middle Aged; Obesity | 1977 |
Predictive factors and mechanism of arrhythmias and myocardial ischaemic changes in elderly patients during barium enema.
Topics: Aged; Arrhythmias, Cardiac; Barium Sulfate; Coronary Disease; Electrocardiography; Enema; Glucagon; Heart; Humans | 1976 |
[Cardiological emergencies in old age].
Topics: Aging; Anticoagulants; Arrhythmias, Cardiac; Cardiac Glycosides; Coronary Disease; Diuretics; Electric Stimulation Therapy; Glomerular Filtration Rate; Glucagon; Heart Diseases; Heart Failure; Humans; Posture; Pulmonary Edema; Pulmonary Embolism | 1975 |
[Use of glucagon in cardiac insufficiency].
Topics: Acute Disease; Adult; Aged; Blood; Chronic Disease; Coronary Disease; Drug Evaluation; Glucagon; Hemodynamics; Humans; Middle Aged; Myocardial Infarction; Rheumatic Heart Disease | 1975 |
[Use of glucagon in the therapy of cardiac insufficiency].
Topics: Adult; Aged; Coronary Disease; Female; Glucagon; Heart Failure; Heart Valve Diseases; Humans; Male; Middle Aged; Pulmonary Edema; Pulmonary Heart Disease | 1976 |
Properties of phosphatidate phosphohydrolase and diacylglycerol acyltransferase activities in the isolated rat heart. Effect of glucagon, ischaemia and diabetes.
Topics: Acyltransferases; Animals; Biological Transport; Coronary Disease; Cytosol; Diabetes Complications; Diabetes Mellitus; Diacylglycerol O-Acyltransferase; Fatty Acids; Glucagon; In Vitro Techniques; Kinetics; Magnesium; Male; Microsomes; Myocardium; Oleic Acids; Phosphatidate Phosphatase; Phosphoric Monoester Hydrolases; Rats | 1990 |
Peptide and steroid hormones in subjects at different risk for diet-related diseases.
Topics: beta-Endorphin; Cholecystokinin; Cholesterol; Coronary Disease; Diet; Diet, Vegetarian; Dietary Fiber; Female; Gastrins; Glucagon; Humans; Insulin; Lipids; Middle Aged; Neoplasms; Obesity; Risk Factors | 1988 |
[Intrapericardial administration of drugs in the animal experiment].
Topics: Animals; Coronary Circulation; Coronary Disease; Digitoxin; Glucagon; Heart Conduction System; Hemodynamics; Myocardial Contraction; Nitroglycerin; Pericardium; Streptokinase; Swine; Swine, Miniature; Vasodilator Agents | 1985 |
Impaired chronotropic response to beta-stimulation in chronic coronary artery disease.
Topics: Adrenergic beta-Agonists; Angiocardiography; Arrhythmias, Cardiac; Atropine; Catecholamines; Coronary Disease; Cyclic AMP; Glucagon; Heart Function Tests; Heart Rate; Hemodynamics; Humans; Isoproterenol; Male; Middle Aged; Physical Exertion; Propranolol; Receptors, Adrenergic | 1973 |
Left ventricular function in patients with coronary artery disease.
Topics: Adult; Blood Pressure; Coronary Angiography; Coronary Artery Bypass; Coronary Disease; Dextrans; Digitalis Glycosides; Electrocardiography; Exercise Test; Glucagon; Heart; Heart Ventricles; Hemodynamics; Humans; Ischemia; Male; Middle Aged; Nitroglycerin; Pacemaker, Artificial; Propranolol; Pulmonary Artery; Ventricular Function | 1973 |
Relationships among hypertrophy, hypertension, and coronary arterial patterns, and pharmacological responses in cardiomyopathies.
Topics: Cardiomegaly; Cardiomyopathy, Hypertrophic; Coronary Disease; Coronary Vessels; Glucagon; Heart Failure; Humans; Hypertension; Phentolamine; Practolol | 1973 |
Efficacy of isoproterenol-glucagon infusion in patients with heart disease.
Topics: Adult; Aged; Aortic Valve Insufficiency; Aortic Valve Stenosis; Blood Pressure; Cardiac Output; Coronary Disease; Cyclic AMP; Drug Synergism; Glucagon; Heart Diseases; Heart Rate; Humans; Isoproterenol; Middle Aged; Mitral Valve Insufficiency; Rheumatic Heart Disease | 1971 |
Method for determination of cyclic AMP in plasma.
Topics: Adrenal Glands; Ammonium Sulfate; Animals; Barium; Carrier Proteins; Chemical Precipitation; Coronary Disease; Cyclic AMP; Cyclic GMP; Dogs; Glucagon; Humans; Methods; Microchemistry; Myocardial Infarction; Norepinephrine; Protein Binding; Rats; Saliva; Species Specificity; Tritium; Zinc | 1973 |
Serum glucagon and insulin levels and their relationship to blood glucose values in patients with acute myocardial infarction and acute coronary insufficiency.
Topics: Adult; Aged; Angina Pectoris; Arteriosclerosis; Blood Glucose; Coronary Disease; Creatine Kinase; Female; Glucagon; Humans; Hyperglycemia; Insulin; Male; Middle Aged; Myocardial Infarction; Radioimmunoassay; Shock, Cardiogenic | 1974 |
[Experimental and clinical studies on effects of glucagon on the ischmic heart].
Topics: Adolescent; Adult; Animals; Child; Coronary Disease; Dogs; Female; Glucagon; Heart; Humans; Isoproterenol; Male; Middle Aged; Myocardial Infarction; Shock, Cardiogenic | 1974 |
Aortic velocity and acceleration measurements in the assessment of coronary heart disease.
Topics: Acute Disease; Angina Pectoris; Aorta; Blood Flow Velocity; Blood Pressure Determination; Cardiac Catheterization; Cardiac Output; Coronary Artery Bypass; Coronary Disease; Electrocardiography; Female; Glucagon; Heart Conduction System; Heart Failure; Heart Ventricles; Humans; Male; Mitral Valve Insufficiency; Myocardial Infarction; Ouabain; Prognosis; Regional Blood Flow | 1974 |
Effects of isoproterenol, l-norepinephrine, and glucagon on myocardial gas tensions in animals with coronary artery stenosis.
Topics: Animals; Blood Pressure; Coronary Circulation; Coronary Disease; Disease Models, Animal; Dogs; Glucagon; Heart Rate; Isoproterenol; Mass Spectrometry; Myocardium; Norepinephrine; Oxygen; Oxygen Consumption; Partial Pressure | 1973 |
Effects of glucagon and isoproterenol on severity of acute myocardial ischemic injury.
Topics: Alcohols; Animals; Blood Pressure; Coronary Disease; Depression, Chemical; Dogs; Electrocardiography; Fatty Acids, Nonesterified; Female; Glucagon; Heart; Heart Rate; Isoproterenol; Lipid Mobilization; Male; Myocardial Infarction; Nicotinic Acids; Stimulation, Chemical | 1973 |
[Glucagon as a life-saving drug].
Topics: Adult; Aged; Coma; Coronary Disease; Female; Glucagon; Heart Arrest; Heart Failure; Humans; Male; Middle Aged; Pulmonary Edema; Pulmonary Heart Disease | 1973 |
Anaerobiosis induced by isoproterenol and glucagon in the presence of restricted coronary inflow.
Topics: Anaerobiosis; Animals; Blood Flow Velocity; Blood Pressure; Cardiac Catheterization; Cardiac Output; Coronary Circulation; Coronary Disease; Coronary Vessels; Dogs; Electrocardiography; Female; Glucagon; Heart Rate; Infusions, Parenteral; Isoproterenol; Lactates; Male; Oxygen Consumption; Pyruvates; Stimulation, Chemical; Transducers; Ventricular Fibrillation | 1974 |
Effect of inotropic agents on the localized dyskinesis of acutely ischemic myocardium. An experimental ultrasound study.
Topics: Animals; Cardiac Output; Coronary Disease; Coronary Vessels; Dogs; Echocardiography; Glucagon; Heart; Heart Aneurysm; Isoproterenol; Ligation; Myocardium; Norepinephrine; Ouabain; Propranolol | 1974 |
Model of human coronary artery disease for acute experimentation.
Topics: Animals; Arteries; Blood Flow Velocity; Blood Pressure; Cardiac Output; Coronary Circulation; Coronary Disease; Coronary Vessels; Depression, Chemical; Disease Models, Animal; Dogs; Electrocardiography; Glucagon; Heart; Heart Ventricles; Ischemia; Isoproterenol; Lactates; Ligation; Myocardium; Time Factors | 1974 |
Human cardiac transplantation: clinical experience.
Topics: Adolescent; Adult; Coronary Disease; Female; Glucagon; Heart; Heart Defects, Congenital; Heart Function Tests; Heart Transplantation; Humans; Isoproterenol; Male; Middle Aged; Mitral Valve; Postoperative Care; Tissue Donors; Transplantation, Homologous; Tricuspid Valve | 1969 |
Hemodynamic evaluation of glucagon in symptomatic heart disease.
Topics: Blood Pressure; Cardiac Catheterization; Cardiac Output; Coronary Disease; Dye Dilution Technique; Glucagon; Heart Diseases; Heart Failure; Heart Rate; Heart Valve Diseases; Humans; Isoproterenol; Stimulation, Chemical; Vascular Resistance | 1971 |
Effects of glucagon on resting and exercise haemodynamics in patients with coronary heart disease.
Topics: Adult; Blood Pressure; Brachial Artery; Cardiac Output; Coronary Disease; Female; Glucagon; Heart Rate; Heart Ventricles; Hemodynamics; Humans; Injections, Intra-Arterial; Male; Middle Aged; Physical Exertion; Pulmonary Artery; Time Factors | 1972 |
Effect of glucagon on automaticity, threshold for stimulation, and atrioventricular conduction in patients with impaired impulse formation or conduction.
Topics: Adult; Aged; Arrhythmias, Cardiac; Arteriosclerosis; Atrial Fibrillation; Coronary Disease; Glucagon; Heart Block; Heart Conduction System; Heart Diseases; Humans; Hypertension; Middle Aged; Pacemaker, Artificial | 1972 |
The effect of glucagon on the coronary circulation in man.
Topics: Adult; Aged; Arteries; Blood Circulation; Blood Flow Velocity; Blood Pressure; Coronary Disease; Coronary Vessels; Female; Glucagon; Heart; Heart Failure; Heart Rate; Heart Ventricles; Hemodynamics; Humans; Infusions, Parenteral; Isoproterenol; Male; Middle Aged; Myocardium; Norepinephrine; Oxygen Consumption; Radioisotope Dilution Technique; Radioisotopes; Regional Blood Flow; Rubidium; Stimulation, Chemical; Vascular Resistance | 1969 |
Potentiation by glucagon of the hypoprothrombinemic action of warfarin.
Topics: Aged; Coronary Disease; Depression, Chemical; Drug Synergism; Female; Glucagon; Humans; Liver; Male; Middle Aged; Prothrombin Time; Pulmonary Embolism; Receptors, Drug; Warfarin | 1970 |
Effects of glucagon on myocardial metabolism in patients with and without coronary artery disease.
Topics: Adult; Aged; Cardiac Output; Coronary Disease; Female; Glucagon; Heart; Hemodynamics; Humans; Ion Exchange; Lactates; Male; Middle Aged; Myocardium; Potassium | 1970 |
Factors influencing infarct size following experimental coronary artery occlusions.
Topics: Animals; Blood Pressure; Bretylium Compounds; Coronary Disease; Creatine Kinase; Dogs; Electric Stimulation; Electrocardiography; Glucagon; Heart; Heart Rate; Isoproterenol; Myocardial Infarction; Myocardium; Ouabain; Oxygen Consumption; Propranolol; Tachycardia | 1971 |
Toxic effects of glucagon-induced acute lipid mobilization in geese.
Topics: Animals; Aspartate Aminotransferases; Blood Glucose; Coronary Disease; Electrocardiography; Fatty Acids, Nonesterified; Geese; Glucagon; Histocytochemistry; L-Lactate Dehydrogenase; Lipid Metabolism; Liver; Microscopy, Electron; Myocardial Infarction; Myocardium; Nicotinic Acids; Propranolol; Sodium Chloride; Tachycardia; Triglycerides | 1968 |